Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332 (20 May), doi:10.1136/bmj.332.7551.0
Patients from different ethnic groups have different risks for adverse reactions to cardiovascular drugs. McDowell and colleagues (p 1177) carried out a meta-analysis of 24 studies containing information on adverse reactions to cardiovascular drugs in at least two different ethnic groups. Among other differences, they found that black patients had a relative risk of angio-oedema due to angiotensin converting enzyme inhibitors of 3.0 compared with non-black patients, and a relative risk of intracranial haemorrhage due to thrombolytic drugs of 1.5. Given these results, studies investigating drug treatment should report racial and ethnic classification more fully.
|
|
Credit: MARK THOMAS/SPL
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?